These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 8928192

  • 1. TNF inhibitor with a low molecular weight found in the human sera.
    Shimoda A, Hanaumi K, Kumagai K.
    Tohoku J Exp Med; 1995 Dec; 177(4):327-35. PubMed ID: 8928192
    [Abstract] [Full Text] [Related]

  • 2. A tumor necrosis factor binding protein is present in human biological fluids.
    Peetre C, Thysell H, Grubb A, Olsson I.
    Eur J Haematol; 1988 Nov; 41(5):414-9. PubMed ID: 2850215
    [Abstract] [Full Text] [Related]

  • 3. Soluble TNF-alpha receptors bind and neutralize over-expressed transmembrane TNF-alpha on macrophages, but do not inhibit its processing.
    Watts AD, Hunt NH, Madigan MC, Chaudhri G.
    J Leukoc Biol; 1999 Dec; 66(6):1005-13. PubMed ID: 10614784
    [Abstract] [Full Text] [Related]

  • 4. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.
    Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL.
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8331-5. PubMed ID: 2172983
    [Abstract] [Full Text] [Related]

  • 5. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy.
    Fujisawa S, Konnai S, Okagawa T, Maekawa N, Tanaka A, Suzuki Y, Murata S, Ohashi K.
    BMC Vet Res; 2019 Feb 28; 15(1):68. PubMed ID: 30819151
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-TNF-alpha therapies: the next generation.
    Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL.
    Nat Rev Drug Discov; 2003 Sep 28; 2(9):736-46. PubMed ID: 12951580
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective release of tumor necrosis factor binding protein II by malignant human epidermal cells reveals protection from tumor necrosis factor alpha-mediated cytotoxicity.
    Neuner P, Klosner G, Pourmojib M, Trautinger F, Knobler R.
    Cancer Res; 1994 Nov 15; 54(22):6001-5. PubMed ID: 7954434
    [Abstract] [Full Text] [Related]

  • 13. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
    Gatanaga T, Hwang CD, Kohr W, Cappuccini F, Lucci JA, Jeffes EW, Lentz R, Tomich J, Yamamoto RS, Granger GA.
    Proc Natl Acad Sci U S A; 1990 Nov 15; 87(22):8781-4. PubMed ID: 2174164
    [Abstract] [Full Text] [Related]

  • 14. Increased levels of soluble TNF-alpha receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis.
    Rysz J, Majewska E, Stolarek RA, Banach M, Ciałkowska-Rysz A, Baj Z.
    Am J Nephrol; 2006 Nov 15; 26(5):437-44. PubMed ID: 16988495
    [Abstract] [Full Text] [Related]

  • 15. A human inhibitor of tumor necrosis factor alpha.
    Seckinger P, Isaaz S, Dayer JM.
    J Exp Med; 1988 Apr 01; 167(4):1511-6. PubMed ID: 2833558
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
    Pennica D, Kohr WJ, Fendly BM, Shire SJ, Raab HE, Borchardt PE, Lewis M, Goeddel DV.
    Biochemistry; 1992 Feb 04; 31(4):1134-41. PubMed ID: 1310420
    [Abstract] [Full Text] [Related]

  • 17. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
    Terlizzese M, Simoni P, Antonetti F.
    J Interferon Cytokine Res; 1996 Dec 04; 16(12):1047-53. PubMed ID: 8974008
    [Abstract] [Full Text] [Related]

  • 18. [Soluble TNF-alpha receptors].
    Jabłońska E.
    Postepy Hig Med Dosw; 1997 Dec 04; 51(5):567-75. PubMed ID: 9489455
    [Abstract] [Full Text] [Related]

  • 19. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
    Nissen-Meyer J, Austgulen R, Espevik T.
    Cancer Res; 1987 May 01; 47(9):2251-8. PubMed ID: 3567918
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of new pyrrolo[2, 3-b]pyridines as a potent inhibitor of tumour necrosis factor alpha.
    Hilmy KM.
    Arch Pharm (Weinheim); 2004 Jan 01; 337(1):15-9. PubMed ID: 14760623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.